A historic shift in our drug policy has taken place, as the government allow the availability of psilocybin mushrooms for therapeutic applications. Previously, these substances were severely restricted, but a mounting body of evidence suggests they potentially offer benefits for psychological illnesses like PTSD. This development represents a subst